Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIPI Trial: BCG to Prevent TB Infection in Healthy Adults
NCT04453293Phase 3Terminated
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Start
- Dec 2021
- Primary completion
- Jan 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of bcg vaccine in Tuberculosis (TB), sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine. Started Dec 2021; status: terminated.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04453293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04453293.